Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00395304 · ClinicalTrials.gov registry record · Phase 3
Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 182
- Enrollment target
NCT00395304 is a Phase 3 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 182 participants.
The verdict
NCT00395304, a Phase 3 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 182 participants
- Enrollment target
Study Summary
Asthma is a common, serious illness among children in the United States. While a low dose of inhaled corticosteroids (ICS) may effectively control symptoms, some children may require additional medications to maintain adequate asthma control. This study compares the effectiveness of a higher dose of ICS, ICS combined with a long-acting beta-agonist (LABA) medication, and ICS combined with a leukotriene receptor antagonist (LTRA) medication at reducing the impact and severity of asthma exacerbations that occur in children with mild to moderate persistent asthma.
Interventions
- DRUG fluticasone propionate
- DRUG fluticasone propionate + montelukast
- DRUG fluticasone propionate + salmeterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00395304
The ClinicalTrials.gov registry entry for NCT00395304 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which fluticasone propionate is the first listed.
NCT00395304 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00395304 about?
NCT00395304 is a clinical study titled "Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)". Asthma is a common, serious illness among children in the United States. While a low dose of inhaled corticosteroids (ICS) may effectively control symptoms, some children may require additional medications to maintain adequate asthma control. This study compares the effectiveness of a higher dose of...
What is the current status of trial NCT00395304?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 182 participants. The study started on 2007-03. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00395304?
The interventions under investigation include: fluticasone propionate (DRUG), fluticasone propionate + montelukast (DRUG), fluticasone propionate + salmeterol (DRUG).
Who is sponsoring clinical trial NCT00395304?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.